The Online Meeting of Kuihua Pharmaceutical Group Co., Ltd. Was Successfully Held

In early 2021, the online meeting between Kuihua Pharmaceutical and a foreign client was successfully held. Airui Global Translation provided translation services for this meeting.

Kuihua Pharmaceutical, namely Kuihua Pharmaceutical Group Co., Ltd., is a private joint - stock enterprise with Heilongjiang Kuihua Pharmaceutical Co., Ltd. as the core. It is a core enterprise of Heilongjiang Kuihua Pharmaceutical Co., Ltd., which was restructured from the former state - owned Wuchang Pharmaceutical Factory on the verge of bankruptcy in April 1998. The group's headquarters is located in the development zone of Harbin. The production bases are respectively located in Wuchang City, Tieli City, Jiamusi City of Heilongjiang Province, Fuling District of Chongqing City, Tangshan City and Hengshui City of Hebei Province. The total assets of the enterprise are 1.28 billion yuan, and the total area is 360,000 square meters. It has offices in 28 provinces (cities) and autonomous regions across the country.

The enterprise can produce nearly 400 kinds of "Zhun" - grade traditional Chinese medicine preparations in 10 dosage forms, forming a series of Kuihua - branded drugs with the liver - protecting tablets and Weikangling capsules, which are independently developed and first - produced, as the leaders, and with kangfu anti - inflammatory suppositories, Tianju naoan capsules and Xiao'er Feire Kechuan oral liquid as the mainstays. The products are sold well throughout the country. The main varieties of Kuihua have been rated as "famous brand products in Heilongjiang Province" four times. In 2010, it was selected as the first government reserve drug for the treatment and prevention of children's influenza A (H1N1) in the country [2]. The Kuihua - branded liver - protecting tablets have won more than 50 domestic and foreign awards including two national silver quality awards (the gold award was vacant) successively. Since 2001, it has become the first - choice brand for the treatment of hepatobiliary diseases in the country, and its sales volume has always ranked first among hepatobiliary drugs in the country. It was recognized as a "national best - selling well - known commodity in 2001" by the Information Center of the National Bureau of Statistics. In July 2002, the Kuihua - branded liver - protecting tablets, Weikangling capsules and Xiao'er Feire Kechuan oral liquid were rated as "quality - reliable good products certified by national authoritative institutions" by the China Quality Certification Standards Association. Among them, the Kuihua - branded Xiao'er Feire Kechuan oral liquid was listed as an emergency reserve drug in Heilongjiang Province and Zhejiang Province during the fight against influenza A.

◀️：Provided Translation for the Bidding Project of a Large Automobile Company

▶️：The "2020 Harvard China Tour" Beijing Station of Harvard University Design School Was Successfully Held